ACKERMANN CHRISTINA
SEC insider (Form 3/4/5 filer). CIK 0001681871. Director at Verona Pharma plc (VRNA). 9 reported Form 4/5 transactions since Sep 2024; latest on Oct 7, 2025. Located in LONDON, X0.
Companies ACKERMANN CHRISTINA has filed insider reports for
- Verona Pharma plc (VRNA): Director
ACKERMANN CHRISTINA
CIK: 0001681871
Transaction Breakdown
Open Market Buys (P)1 (11.1%)
High conviction signal
Open Market Sales (S)2 (22.2%)
Position reduction
Option Exercises (M)3 (33.3%)
Derivative conversions
Awards (A)1 (11.1%)
Compensation grants
Other (G, F, J, C, D, …)2 (22.2%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VRNA
Verona Pharma plc
Director
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Oct 7, 2025VRNA
Verona Pharma plc
ExerciseDirect72K shares- - Oct 7, 2025VRNA
Verona Pharma plc
DispositionDirect64.1K shares- - Oct 7, 2025VRNA
Verona Pharma plc
DispositionDirect72K shares- - Aug 1, 2025VRNA
Verona Pharma plc
SaleDirect1.8K shares at avg. $13.14$24K - Aug 1, 2025VRNA
Verona Pharma plc
ExerciseDirect24K shares- - May 14, 2025VRNA
Verona Pharma plc
ExerciseDirect40K shares at avg. $1.93$77K - May 14, 2025VRNA
Verona Pharma plc
SaleDirect40K shares at avg. $8.44$338K - Apr 25, 2025VRNA
Verona Pharma plc
AwardDirectRestricted Share Units
96K shares- - Nov 6, 2024VRNA
Verona Pharma plc
PurchaseDirect41.9K shares at avg. $4.74$198K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 7, 2025 | VRNA Verona Pharma plc | Exercise | 72,000 | - | - | Direct |
| Oct 7, 2025 | VRNA Verona Pharma plc | Disposition | 64,072 | - | - | Direct |
| Oct 7, 2025 | VRNA Verona Pharma plc | Disposition | 72,000 | - | - | Direct |
| Aug 1, 2025 | VRNA Verona Pharma plc | Sale | 1,808 | $13.14 | $23,764 | Direct |
| Aug 1, 2025 | VRNA Verona Pharma plc | Exercise | 24,000 | - | - | Direct |
| May 14, 2025 | VRNA Verona Pharma plc | Exercise | 40,000 | $1.93 | $77,352 | Direct |
| May 14, 2025 | VRNA Verona Pharma plc | Sale | 40,000 | $8.44 | $337,600 | Direct |
| Apr 25, 2025 | VRNA Verona Pharma plc | Award Restricted Share Units | 96,000 | - | - | Direct |
| Nov 6, 2024 | VRNA Verona Pharma plc | Purchase | 41,880 | $4.74 | $198,386 | Direct |
1-9 of 9 transactions